Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating cabozantinib in combination with pembrolizumab for metastatic gastric cancer and gastroesophageal cancer; results h…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 [NA]
Phase 2 trial investigating an end-of-life conversation game to engage cancer patients in advance care planning; the study is currently acti…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Prediction of Occult Peritoneal Metastasis of Locally Advanced Gastric Cancer Using Multimodal Data Based on Artificial Intelligence Combined With Intraoperative Dynamic Video
A completed clinical trial evaluated using multimodal data and intraoperative dynamic video to predict occult peritoneal metastasis in local…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Comparison of Safety and Clinical Effects of Straight and Articulated Instruments (ArtiSential) in Laparoscopic Gastrectomy for Gastric Cancer Patients, a Prospective Randomized Study [NA]
A prospective randomized study comparing the safety and clinical effects of Straight versus Articulated ArtiSential instruments in laparosco…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT [NA]
Completed clinical trial comparing 18F-AlF-FAPI PET/CT with 18F-FDG PET/CT in patients with gastric cancer, pancreatic cancer, and hepatocel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 neoadjuvant trial evaluating trastuzumab, with or without pertuzumab, in patients with gastric or gastroesophageal junction adenoc…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: A Multifactor Prediction Model for Non-curative Outcomes in Mixed-type Early Gastric Cancer
This completed clinical trial evaluates a multifactor prediction model for non-curative outcomes in mixed-type early gastric cancer.
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer [Phase 1, Phase 2]
A Phase Ib/II neoadjuvant trial evaluating zolbetuximab with docetaxel, oxaliplatin and S-1 in locally advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric Cancer [NA]
The clinical trial NCT05541783, sponsored by Fudan University, has completed evaluating laparoscopic-assisted distal gastrectomy and totally…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Annual Hospital Volume and and Short-term Postoperative Outcomes After Gastric Cancer Resection
A completed clinical trial evaluating annual hospital volume and its association with short-term postoperative outcomes after gastric cancer…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia
AstraZeneca's clinical trial in Russia evaluating HER2-positive gastric and gastroesophageal junction adenocarcinoma has completed (NCT05892…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Predicting the Efficacy in Advanced Gastric Cancer.
This update reports a completed clinical trial assessing predicted efficacy in advanced gastric cancer. The study involves paclitaxel and ra…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
NuCana plc announced termination of a Phase 1/2 trial evaluating NUC-3373 in combination with other agents for patients with advanced solid …
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM [Phase 2]
Phase 2 trial evaluating the efficacy and safety of HIPEC combined with a PD-1 inhibitor and S-1 plus oxaliplatin chemotherapy in metastatic…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of INCB106385, alone or with immunotherapy, in advanced solid tumors has completed. The study includes multiple indications …
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors [Phase 2]
Telix's phase 2 trial of the CAIX-targeting PET tracer 89Zr-girentuximab in CAIX-positive solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers [Phase 2]
Phase 2 study evaluating adoptive transfer of tumor-infiltrating lymphocytes (TIL) for advanced solid cancers, with multiple site-specific i…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating the combination of berzosertib with irinotecan for TP53-mutant advanced gastric or gastroesophageal junction cancer…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: A Study on Immunotherapy Combined With Radiotherapy for Esophagogastric Junction/Gastric Adenocarcinoma [Phase 2]
Phase 2 study evaluating immunotherapy combined with radiotherapy for gastroesophageal junction and gastric adenocarcinoma; currently not re…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer [Phase 1]
Phase 1 dose-escalation study of lithium in combination with oxaliplatin and capecitabine for advanced esophago-gastric or colorectal cancer…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology [Phase 4]
Phase 4 trial evaluating the effects of high-dose dual therapy and bismuth quadruple therapy for Helicobacter pylori eradication on intestin…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer [Phase 3]
A Phase 3 clinical trial comparing neoadjuvant chemoradiotherapy to chemotherapy followed by radical gastrectomy and adjuvant chemotherapy f…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing Vonorazon plus Amoxicillin dual therapy versus a bismuth-containing quadruple regimen for Helicobacter pylori-relate…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) [Phase 2]
This is a Phase 2 master protocol evaluating SAR444245 in combination with other anticancer therapies for several gastrointestinal cancers; …
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer [Phase 3]
A Phase 3 trial in stage III gastric cancer is evaluating whether circulating tumor DNA (ctDNA) can guide treatment decisions.